StageZero Life Sciences Ltd (SZLS) - Cash Flow Conversion Efficiency

Latest as of September 2024: 0.013x

Based on the latest financial reports, StageZero Life Sciences Ltd (SZLS) has a cash flow conversion efficiency ratio of 0.013x as of September 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-145.57K ≈ $-105.30K USD) by net assets (CA$-11.13 Million ≈ $-8.05 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See StageZero Life Sciences Ltd balance sheet quality to measure how much of total assets are equity-financed.

StageZero Life Sciences Ltd - Cash Flow Conversion Efficiency Trend (1998–2022)

This chart illustrates how StageZero Life Sciences Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check earnings quality score of StageZero Life Sciences Ltd to evaluate the quality of earnings relative to operating cash generation.

StageZero Life Sciences Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of StageZero Life Sciences Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Accelerate Resources Ltd AU:AX8	-0.037x
Super Spinning Mills Limited NSE:SUPERSPIN	0.038x
Forterra PLC LSE:FORT	0.109x
New Sources Energy N.V AS:NSE	0.001x
Future PLC LSE:FUTR	0.068x
EPRCOMUNICAZIONE S.P.A. F:J3P	N/A
California Software Company Limited NSE:CALSOFT	-0.032x
Yari Minerals Ltd AU:YAR	-1.583x

Annual Cash Flow Conversion Efficiency for StageZero Life Sciences Ltd (1998–2022)

The table below shows the annual cash flow conversion efficiency of StageZero Life Sciences Ltd from 1998 to 2022. For the full company profile with market capitalisation and key ratios, see SZLS stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2022-12-31	CA$-7.50 Million ≈ $-5.43 Million	CA$-3.53 Million ≈ $-2.55 Million	0.470x	+114.50%
2021-12-31	CA$2.76 Million ≈ $2.00 Million	CA$-8.95 Million ≈ $-6.48 Million	-3.242x	-230.51%
2020-12-31	CA$-1.23 Million ≈ $-892.28K	CA$-3.06 Million ≈ $-2.22 Million	2.484x	+143.05%
2019-12-31	CA$-4.49 Million ≈ $-3.25 Million	CA$-4.59 Million ≈ $-3.32 Million	1.022x	+50.23%
2018-12-31	CA$-4.84 Million ≈ $-3.50 Million	CA$-3.29 Million ≈ $-2.38 Million	0.680x	-46.33%
2017-12-31	CA$-3.02 Million ≈ $-2.18 Million	CA$-3.82 Million ≈ $-2.77 Million	1.268x	+62.76%
2016-12-31	CA$-4.73 Million ≈ $-3.42 Million	CA$-3.68 Million ≈ $-2.66 Million	0.779x	-20.01%
2015-12-31	CA$-1.77 Million ≈ $-1.28 Million	CA$-1.73 Million ≈ $-1.25 Million	0.974x	+236.66%
2014-12-31	CA$2.15 Million ≈ $1.56 Million	CA$-1.54 Million ≈ $-1.11 Million	-0.713x	+71.36%
2013-12-31	CA$1.74 Million ≈ $1.26 Million	CA$-4.34 Million ≈ $-3.14 Million	-2.488x	-210.51%
2012-12-31	CA$5.07 Million ≈ $3.67 Million	CA$-4.06 Million ≈ $-2.94 Million	-0.801x	-109.11%
2011-12-31	CA$-321.56K ≈ $-232.61K	CA$-2.83 Million ≈ $-2.05 Million	8.800x	+131.32%
2010-12-31	CA$87.69K ≈ $63.43K	CA$-2.46 Million ≈ $-1.78 Million	-28.100x	-1417.74%
2009-12-31	CA$2.49 Million ≈ $1.80 Million	CA$-4.61 Million ≈ $-3.34 Million	-1.851x	+57.36%
2008-12-31	CA$1.73 Million ≈ $1.25 Million	CA$-7.51 Million ≈ $-5.43 Million	-4.342x	-622.04%
2007-12-31	CA$13.81 Million ≈ $9.99 Million	CA$-8.31 Million ≈ $-6.01 Million	-0.601x	-88.69%
2006-12-31	CA$19.54 Million ≈ $14.13 Million	CA$-6.23 Million ≈ $-4.51 Million	-0.319x	-80.16%
2005-12-31	CA$5.93 Million ≈ $4.29 Million	CA$-1.05 Million ≈ $-758.95K	-0.177x	+45.23%
2004-12-31	CA$7.69 Million ≈ $5.56 Million	CA$-2.48 Million ≈ $-1.80 Million	-0.323x	-294.68%
2003-12-31	CA$5.74 Million ≈ $4.15 Million	CA$-469.80K ≈ $-339.85K	-0.082x	+80.16%
2002-12-31	CA$1.71 Million ≈ $1.24 Million	CA$-707.49K ≈ $-511.78K	-0.413x	+9.50%
2001-12-31	CA$2.29 Million ≈ $1.66 Million	CA$-1.04 Million ≈ $-755.27K	-0.456x	+43.12%
2000-12-31	CA$2.32 Million ≈ $1.68 Million	CA$-1.86 Million ≈ $-1.34 Million	-0.801x	+6.73%
1999-12-31	CA$34.76K ≈ $25.15K	CA$-29.87K ≈ $-21.61K	-0.859x	-2739.35%
1998-12-31	CA$165.36K ≈ $119.62K	CA$-5.00K ≈ $-3.62K	-0.030x	--

About StageZero Life Sciences Ltd

TO:SZLS Canada Diagnostics & Research

Market Cap

$3.58 Million

CA$4.94 Million CAD

Market Cap Rank

#29136 Global

#1345 in Canada

Share Price

CA$0.04

Change (1 day)

+0.00%

52-Week Range

CA$0.04 - CA$0.04

All Time High

CA$4.16